Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2026-06-05 16:44:52 ET · period of report 2026-06-03 · accession 0001816206-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:44 | 2026-06-03 | DNLI | Van Hauwermeiren Timothy | Dir | A - Grant | $0.00 | +6,408 | 17.0K | +60% | $0 |
| D | 2026-06-05 16:44 | 2026-06-03 | DNLI | Van Hauwermeiren Timothy | Dir | A - Grant | $0.00 | +19.2K | 19.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-03 | A | A | 6,408 | $0.00 | 17,040 | D | — | — | (F1) Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. (F2) Includes 17,040 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2026-06-03 | A | A | 19,226 | $0.00 | 19,226 | D | $19.66 · — to 2036-06-03 | 19,226 Common Stock | (F3) 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. |